Express Pharma
Home  »  Latest Updates  »  Lupin’s Mandideep facility inspection completed by ANSM

Lupin’s Mandideep facility inspection completed by ANSM

0 120
Read Article

The inspection closed with no critical or major observations

Drug firm Lupin on Tuesday said inspection of a unit of its Mandideep facility in Madhya Pradesh by the French National Agency for Medicines and Health Products Safety (ANSM) has been completed with no major observations.

The good manufacturing practices (GMP) inspection of company’s finished product manufacturing facility (Unit-1) at Mandideep by the ANSM has been completed, Lupin said in a statement.

The inspection was conducted between April 8 to April 12, 2019, it added.

“The ANSM inspection closed with no critical or major observations,” Lupin said

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Want to know more about "Omic's" and it's relevance?
Register Now
close-image